Rivulet Media Inc (fka RIVU)

[relyts]

http://regenbiopharma.com/advisory-board.html

"Weiping Min, M.D.
Dr. Min is Associate Professor, Department of Surgery at the University of Western Ontario. His clinical research is focused on using siRNA to inhibit disease modalities, including cancer and organ rejection. He earned graduate and medical degrees from Nanchang University Medical School and the Ph.D. degree from Kyushu University."

http://www.researchgate.net/profile/Wei-Ping_Min/

Publications (53)

http://www.tolerotech.com/research/paper_print/MAI_2005_RNAi.pdf

Old article - Co-authored by:

Thomas E Ichim (CEO of Medistem / Co-author of Regen BioPharma's publication)
Mu Li
Hua Qian
Igor A Popov
Katarzyna Rycerz
Robert Zhong
Wei-Ping Min

They go way back.

http://www.uwo.ca/pathol/faculty/min.html

"M Suzuki, X Zheng, X Zhang, M Li, C Vladau, TE Ichim, H Sun, B Garcia, and W-P Min. Novel therapy for allergy through gene silencing of CD40 using siRNA. J Immunol. 2008, 180(12):8461-9.
X Zheng, X Zhang, B Feng, H Sun, M Suzuki, N Kubo, A Wong, LR Min, ME Bedohn, B Garcia, AM Jevnikar, and W-P Min. Gene silencing of complement C5a receptor using siRNA for preventing ischemia-reperfusion injury. Am J Pathol. 2008, In press.
M Li, X Zhang, X Zheng, D Lian, Z-X Zhang, W Ge, J Yang, C Vladau, , M Suzuki, D Chen, R Zhong, B Garcia, AM Jevnikar and W-P Min: Immune modulation and tolerance induction by RelB-silenced dendritic cells. J Immunol. 2007, 178(9):5480-7.
X Zheng, J Koropatnick, M Li, X Zhang, F Ling, X Ren, X Hao, H Sun, C Vladau, JA Frignet, IA PopovBL Urquhart, R Zhong, DJ Freeman, B Garcia and W-P Min. Reinstalling anti-cancer immunity by inhibiting tumor-derived immune suppression through RNA interference. J Immunol. 2006; 177:5639-46.
JA Hill, TE Ichim, KP Kusznieruk, M Li, X Huang, X Yan, R Zhong, E Cairns, DA Bell and W-P Min. Immune modulation by silencing IL-12 production in dendritic cells using small interfering RNA. J. Immunol. 2003, 171 (2): 691-6.
X Zheng, C Vladau, X Zhang1, M Suzuki, T Ichim, M Li, B Garcia, AM Jevnikar and W-P Min. A novel in vivo siRNA delivery system specifically targeting dendritic cells and silencing CD40 genes for immunomodulation. Blood 2009, 113(12):2646-54.
M Suzuki, X Zheng, X Zhang, M Li, C Vladau, TE Ichim, H Sun, B Garcia, and W-P Min. Novel therapy for allergy through gene silencing of CD40 using siRNA. J Immunol. 2008, 180(12):8461-9.
X Zheng, X Zhang, B Feng, H Sun, M Suzuki, N Kubo, A Wong, LR Min, ME Bedohn, B Garcia, AM Jevnikar, and W-P Min. Gene silencing of complement C5a receptor using siRNA for preventing ischemia-reperfusion injury. Am J Pathol. 2008,173: 973-980..
M Li, X Zhang, X Zheng, D Lian, Z-X Zhang, W Ge, J Yang, C Vladau, , M Suzuki, D Chen, R Zhong, B Garcia, AM Jevnikar and W-P Min: Immune modulation and tolerance induction by RelB-silenced dendritic cells. J Immunol. 2007, 178(9):5480-7.
X Zheng, J Koropatnick, M Li, X Zhang, F Ling, X Ren, X Hao, H Sun, C Vladau, JA Frignet, IA PopovBL Urquhart, R Zhong, DJ Freeman, B Garcia and W-P Min. Reinstalling anti-cancer immunity by inhibiting tumor-derived immune suppression through RNA interference. J Immunol. 2006; 177:5639-46."